Incannex Healthcare Inc

IXHLNASDAQ · USD
3.32USD0.00 (-2.36%)
812

Incannex Healthcare Inc (IXHL) Covered Calls

As of September 25, 2026, IXHL has 1 covered call opportunities in the coming three months. Return ranges from 22.0 to 22.0% until expiration. Annualized return ranges from 95.5 to 95.5%. The nearest expiration is December 18, 2026. Maximum potential profit is $73.

Read more

Running IXHL covered calls helps you generate consistent income from Incannex Healthcare Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Incannex Healthcare Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best IXHL covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if IXHL stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling IXHL covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Incannex Healthcare Inc covered call is worth writing.

Incannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid products in Australia. It offers pharmaceutical grade cannabinoid products under the Incannex brand name. The company's products include IHL-42X, which is in Phase II clinical trials for obstructive sleep apnea; IHL-216A for traumatic brain injury; and IHL-675A, a combination of hydroxychloroquine and cannabidiol for the prevention and treatment of inflammatory lung conditions, such as acute respiratory distress syndrome, chronic obstructive pulmonary disease, asthma, and bronchitis, as well as rheumatoid arthritis and inflammatory bowel diseases.

It has partnership with The Alfred Hospital and Novotech on IHL-42X clinical program for obstructive sleep apnea; and Monash Trauma Group at the Department of Neuroscience, Monash University to conduct a study on the protective effect of IHL-216A in sports concussion. The company was formerly known as Impression Healthcare Limited and changed its name to Incannex Healthcare Limited in June 2020. Incannex Healthcare Limited was incorporated in 2001 and is based in Sydney, Australia.

Income-focused investors, long-term IXHL holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling IXHL covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Incannex Healthcare Inc covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryDrug Manufacturers - Specialty & Generic
  • SectorHealthcare
  • IV percentile—
  • Market cap (M$)40
  • 52 weeks high-83.16%
  • 52 weeks low33.33%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$18.00
    442.17% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-13
  • P/E—
  • Future P/E—
  • EPS (ttm)-17.18
  • EPS growth next 5 years—

As of September 25, 2026

2026-12-18844.0020.480.051.2073.0021.9995.54-1.51+0.5211.15

As of September 25, 2026

Sell covered calls with the data behind you

Find the best IXHL covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial